Cargando…
Medicines as a service : a new commercial model for big pharma in the postblockbuster world /
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Santa Monica, CA :
RAND Health,
[2012]
|
| Colección: | Occasional paper (Rand Corporation)
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | JSTOR_ocn893183697 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 140829s2012 cau ob 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c NLM |d EBLCP |d MHW |d E7B |d STF |d KLG |d S4S |d JSTOR |d OCLCF |d DEBSZ |d YDXCP |d AU@ |d NKT |d CUS |d ZCU |d MERUC |d OCLCQ |d COCUF |d LND |d OCLCO |d VFL |d OCLCA |d U3W |d OCLCA |d LOA |d ICG |d WRM |d OCLCQ |d NRAMU |d OCLCA |d VT2 |d EZ9 |d OCLCQ |d TKN |d DKC |d OCLCQ |d OCLCO |d OCL |d PIFAG |d N$T |d AGLDB |d COO |d D6H |d VNS |d VTS |d AJS |d OCLCQ |d OCLCO | ||
| 016 | 7 | |a 101640300 |2 DNLM | |
| 019 | |a 804665552 |a 818105683 |a 842699759 |a 903663785 |a 907209128 | ||
| 020 | |a 9780833076465 | ||
| 020 | |a 0833076469 | ||
| 020 | |a 9780833076458 |q (electronic bk.) | ||
| 020 | |a 0833076450 |q (electronic bk.) | ||
| 029 | 0 | |a NLM |b 101640300 | |
| 029 | 1 | |a AU@ |b 000050968007 | |
| 029 | 1 | |a AU@ |b 000052909815 | |
| 029 | 1 | |a AU@ |b 000053024048 | |
| 029 | 1 | |a CHNEW |b 000619499 | |
| 029 | 1 | |a DEBBG |b BV044167510 | |
| 029 | 1 | |a DEBSZ |b 397356706 | |
| 029 | 1 | |a GBVCP |b 1008662488 | |
| 029 | 1 | |a NZ1 |b 14692729 | |
| 029 | 1 | |a DEBSZ |b 493158170 | |
| 035 | |a (OCoLC)893183697 |z (OCoLC)804665552 |z (OCoLC)818105683 |z (OCoLC)842699759 |z (OCoLC)903663785 |z (OCoLC)907209128 | ||
| 037 | |b 00022221 | ||
| 037 | |a 22573/ctt99zkn |b JSTOR | ||
| 042 | |a nlmcopyc | ||
| 050 | 4 | |a HV5840 |b .M38 2012 | |
| 060 | 0 | 0 | |a WT 500 |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 362.29/90941 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Mattke, Soeren. | |
| 245 | 1 | 0 | |a Medicines as a service : |b a new commercial model for big pharma in the postblockbuster world / |c Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu. |
| 260 | |a Santa Monica, CA : |b RAND Health, |c [2012] | ||
| 300 | |a 1 online resource (1 PDF file (11 pages)) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Occasional paper | |
| 500 | |a Title from PDF caption. | ||
| 504 | |a Includes bibliographical references. | ||
| 520 | 3 | |a The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services related to prescription drugs for chronic conditions. We argue that such innovation beyond the pill is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. Our argument is based on the fact that, although effective medicines for most chronic conditions exist, access and adherence to medicines are far from what would be needed to achieve full treatment efficacy. Therefore, value can be created by getting and keeping more patients on their drugs, and innovative business models would allow pharmaceutical companies to capture that value. | |
| 588 | 0 | |a Version viewed Sept. 9, 2014. | |
| 505 | 0 | |a Medicines as a Service. | |
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 590 | |a JSTOR |b Books at JSTOR Open Access | ||
| 650 | 0 | |a Pharmaceutical services. | |
| 650 | 0 | |a Pharmaceutical industry. | |
| 650 | 0 | |a Mathematical models. | |
| 650 | 1 | 2 | |a Chronic Disease |x drug therapy |
| 650 | 2 | 2 | |a Drug Industry |x economics |
| 650 | 2 | 2 | |a Medication Adherence |
| 650 | 2 | 2 | |a Developing Countries |
| 650 | 2 | 2 | |a Models, Theoretical |
| 650 | 2 | |a Pharmaceutical Services | |
| 650 | 2 | |a Drug Industry | |
| 650 | 6 | |a Services pharmaceutiques. | |
| 650 | 6 | |a Industrie pharmaceutique. | |
| 650 | 6 | |a Modèles mathématiques. | |
| 650 | 7 | |a mathematical models. |2 aat | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Mathematical models |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |2 fast | |
| 650 | 7 | |a Pharmaceutical services |2 fast | |
| 700 | 1 | |a Klautzer, Lisa. | |
| 700 | 1 | |a Mengistu, Tewodaj. | |
| 710 | 2 | |a RAND Health. | |
| 776 | 0 | 8 | |i Print version: |a Mattke, Soeren. |t Medicines as a Service : A New Commercial Model for Big Pharma in the Postblockbuster World. |d Santa Monica : RAND Corporation, ©2012 |
| 830 | 0 | |a Occasional paper (Rand Corporation) | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.7249/op381hlth |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL981579 | ||
| 938 | |a ebrary |b EBRY |n ebr10583965 | ||
| 938 | |a YBP Library Services |b YANK |n 9454829 | ||
| 938 | |a EBSCOhost |b EBSC |n 471726 | ||
| 938 | |a YBP Library Services |b YANK |n 10887288 | ||
| 994 | |a 92 |b IZTAP | ||